FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the pharmaceutical industry and represents a local pharmaceutical composition for treating rosacea containing at least 0.02% berberine or a biologically equivalent berberine analogue, such as palmatine, and an ingredient specified in a group consisting of water, methanol, ethanol and dimethylsulphoxide, wherein berberine or the biologically equivalent berberine analogue represents the major pharmaceutically active ingredient.
EFFECT: invention provides extending the range of products for treating rosacea.
4 cl, 6 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING BERBERINE OR ANALOGS THEREOF FOR TREATING ROSACEA OR RED FACE RELATED SKIN DISORDERS | 2014 |
|
RU2671492C2 |
| THERAPEUTIC USE OF MEDICINAL FORMS OF BERBERINE | 2016 |
|
RU2733743C2 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF SKIN DISEASES AND CONDITIONS CONTAINING 7-(1H-IMIDAZOL-4-YLMETHYL)-5,6,7,8-TETRAHYDROQUINOLINE | 2012 |
|
RU2630978C2 |
| METHOD FOR TREATING DISEASES AND CONDITIONS OF THE EYE | 2012 |
|
RU2667645C1 |
| THERAPEUTIC AGENT FOR INHIBITION OF PHOSPHODIESTERASE AND ASSOCIATED PATHOLOGICAL DISORDERS | 2018 |
|
RU2815010C2 |
| PHARMACEUTICAL CREAM COMPOSITION OF OXYMETAZOLINE FOR TREATING SYMPTOMS OF ROSACEA | 2012 |
|
RU2648439C2 |
| METHOD OF TREATMENT OF ROSACEA | 2020 |
|
RU2811956C2 |
| L-SERINE APPLICABLE AS THERAPEUTIC AGENT FOR PREVENTING AND/OR TREATING INFLAMMATORY SKIN RESPONSES | 2010 |
|
RU2554482C2 |
| METHOD OF PREPARING WATER-SOLUBLE PHARMACEUTICAL COMPOSITION BASED ON BERBERINE | 2023 |
|
RU2814497C1 |
| TETRAPEPTIDES OBTAINED FROM HUMAN SYNTHETIC CHEMICALS SUITABLE FOR TREATING DIFFERENT SKIN CONDITIONS | 2014 |
|
RU2687151C2 |
